ALNYLAM PHARMACEUTICALS INC (ALNY)

US02043Q1076 - Common Stock

149.45  -4.94 (-3.2%)

After market: 149.45 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
ASSETS
Current Assets
Cash Equivalents
812.69M866.40M820.00M496.60M547.20M
Marketable Securities
1.63B1.33B1.62B1.38B989.00M
Receivables
327.79M238.00M198.60M602.40M43.00M
Inventories
89.15M129.00M86.40M75.20M56.30M
Other Current Assets
126.38M132.90M88.10M62.80M80.30M
Total Current Assets
2.98B2.69B2.81B2.61B1.72B
 
Non-Current Assets
PPE Net
725.79M738.60M733.60M706.50M646.40M
Investments And Advances
N/AN/AN/AN/AN/A
Other Non-Current Assets
121.39M115.50M101.10M85.80M32.90M
Total Non-Current Assets
847.18M854.20M834.70M792.30M679.20M
 
TOTAL ASSETS
3.83B3.55B3.64B3.41B2.40B
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accrued Expenses
754.52M587.40M435.70M392.80M224.90M
Accounts Payable
55.52M98.10M73.40M52.00M49.90M
Other Current Liabilities
157.74M82.40M186.60M140.50M77.80M
Total Current Liabilities
967.79M767.90M695.70M585.30M352.60M
 
Non-Current Liabilities
Long Term Debt
1.02B1.02B675.70M191.30M0.00
Other Non-Current Liabilities
2.06B1.92B1.68B1.61B603.80M
Total Non-Current Liabilities
3.08B2.94B2.36B1.81B603.80M
 
TOTAL LIABILITIES
4.05B3.70B3.06B2.39B956.40M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-7.01B-6.57B-5.44B-4.59B-3.73B
Additional Paid In Capital
6.81B6.45B6.06B5.64B5.20B
Common Shares
1.26M1.20M1.20M1.20M1.10M
Other Shareholders' Equity
7.87M-2.40M1.20M-11.20M-3.90M
Shares Outstanding
125.79M123.90M120.20M116.40M112.20M
Tangible Book Value per Share
-1.75-1.284.898.7312.82
Total Shareholders' Equity
-220.64M-158.20M588.20M1.02B1.44B
 
TOTAL LIABILITIES AND EQUITY
3.83B3.55B3.64B3.41B2.40B
 
Statistics
Debt/Equity
-4.63-6.431.150.19N/A
Current Ratio
3.083.514.044.474.87
Return On Assets (ROA)
-11.49%-31.90%-23.41%-25.19%-37.00%
Return On Equity (ROE)
N/AN/A-144.98%-84.46%-61.59%

All data in USD

Charts